Showing results (561-570 of 12,170) with videos related to

Sort By:
Pageof 1,217
Journal of Cardiovascular Pharmacology|April 1, 1997
Relaxant actions of nonprostanoid prostacyclin mimetics on human pulmonary arteryR L Jones, Y M Qian, H Wise, et al.
Journal of Cardiovascular Pharmacology|April 1, 1997
Role of nitric oxide in substance P-induced vasodilation differs between the coronary and forearm circulation in humansT Tagawa, M Mohri, H Tagawa, et al.
Journal of Cardiovascular Pharmacology|April 1, 1997
The role of nitric oxide in modulating ischaemia-induced arrhythmias in ratsW Sun, C L Wainwright
Journal of Cardiovascular Pharmacology|April 23, 2015
TVP1022: A Novel Cardioprotective Drug Attenuates Left Ventricular Remodeling After Ischemia/Reperfusion in PigsAssaf Malka, David Meerkin, Yaron D Barac, et al.
Journal of Cardiovascular Pharmacology|May 8, 2020
Thrombocytopenia During Prostacyclin Analogue Therapies of Pulmonary Arterial Hypertension-Possible Pathomechanisms and ImplicationsGrzegorz Grześk, Danuta Karasek, Mateusz Kusiak
Journal of Cardiovascular Pharmacology|September 17, 2009
Angiotensin type 1 receptor expression and interleukin-8 production in polymorphonuclear leukocytes of patients with peripheral arterial diseaseFranca Marino, Luigina Guasti, Matteo Tozzi, et al.
Journal of Cardiovascular Pharmacology|September 17, 2009
Postinfarct treatment with oxytocin improves cardiac function and remodeling via activating cell-survival signals and angiogenesisHiroyuki Kobayashi, Shinji Yasuda, Narentuoya Bao, et al.
Journal of Cardiovascular Pharmacology|January 27, 2011
Physiological and pharmacological roles of vascular nucleoside transportersRachel W S Li, Cui Yang, Albert S M Sit, et al.
Journal of Cardiovascular Pharmacology|January 27, 2011
Vernakalant selectively prolongs atrial refractoriness with no effect on ventricular refractoriness or defibrillation threshold in pigsJeff Bechard, John Ken Gibson, Cheryl R Killingsworth, et al.
Pageof 1,217